Q1 2017

Filed Apr 28, 2017 · 10-Q · 28 days after period end · 0001654954-17-003780

Q1 2017 · 10-Q

Revenue

$0.00

— vs Q1 2016

Net Income

-$5.06M

N/M vs Q1 2016

EPS Diluted

-$26.36

N/M vs Q1 2016

Gross Profit$0—

Operating Income

Same quarter

Metric	Q1 2017	Q1 2016	Q1 2015	Q1 2014
Revenue	$0.00	$0.00	$7.00K	$0.00
Net Income	-$5.06M	$14.68M	-$20.52M	-$371.00K
EPS Diluted	-$26.36	$0.84	-$8.61	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR